Table 1 Target product profiles (TPPs) for SARS-CoV-2 viral detection tests from the MHRAÂ [22]
From: Sample size determination for point-of-care COVID-19 diagnostic tests: a Bayesian approach
TPP | Sensitivity (95% CI) | Specificity (95% CI) |
|---|---|---|
Acceptable | 80% (70–100%) | 95% (90–100%) |
Desirable | 97% (93–100%) | 99% (97–100%) |